2 ms·
> The technology to make monoclonal antibodies is simpler than that for mRNA vaccines. It’s more mature technology, but unlike the mRNA vaccines it’s not cell
by johncolanduoni 5y ago
> The technology to make monoclonal antibodies is simpler than that for mRNA vaccines.
It’s more mature technology, but unlike the mRNA vaccines it’s not cell free and as a result is harder to scale up. At similar scale mRNA will still be cheaper; that’s one if mRNA’s biggest selling points.